Navigation Links
SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
Date:5/16/2008

ogy company developing protein-based pharmaceuticals for metabolic and cardiovascular diseases. The Company's lead pharmaceutical candidates, produced in the plant host safflower, are recombinant human insulin to serve the rapidly expanding global diabetes market and Apo AI, a next generation cardiovascular drug. In addition to its pharmaceutical products, SemBioSys is developing a series of non-pharmaceutical products addressing human topical, nutritional oils and agricultural biotechnology markets. More information is available and can be accessed at http://www.sembiosys.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and other similar expressions which constitute "forward-looking information" within the meaning of applicable Canadian securities laws. Forward-looking statements reflect the Company's current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time-to-time in the Company's ongoing filings with the Canadian securities regulatory authorities which filings can be found at http://www.sedar.com. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. SemBioSys receives milestone payments from AVAC Ltd.
11. SemBioSys announces first quarter 2008 financial and operational results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...T, Israel and JERSEY CITY, New Jersey, July 3,/PRN...: ROSG ), a leading,developer of microRNA-based d...ll present Collins Stewart Fourth Annual Growth Co...he Mandarin Oriental Hotel in New,York., About Ro... is a leader in the field of microRNA.,Founded in ...
(Date:7/2/2008)..., Austria, July 3 /- Nabriva Therapeu...ounces that Dr. George Golumbeski,has been appoint.... Golumbeski brings to the team nearly twenty year...Vice President of Business Development,Licensing ...tis. In this,position he was responsible for the f...
(Date:7/2/2008)...E V, Only Drug Eluting Stent to Demonstrate Superi..., Now Available in United States for ...PARK, Ill., July 2 /- Abbot...nistration (FDA) approved the,XIENCE(TM) V Everoli...t of,coronary artery disease. XIENCE V is the only...
(Date:7/2/2008)... Moore named as Vice President, Marketing and Sale..., Corporate Development, PT. RICHMOND, Calif., Ju...c. today announced the appointment of Terrence Moo...d Sales and Susan Koppy to the position of Vice,Pr... Ms. Koppy will report,to President & Chief Execut...
Breaking Biology Technology:Nabriva Therapeutics Announces Appointment of New CEO 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4
...rms that use slogans and catchy buzz-phrases to ca...ve ear of executive management. Economic developme... those slogans. , ,When a slogan or phrase rings ...des faster than the T-shirts and hats it is printe...ecause future economic viability is going to hinge...
...n Milwaukee and perhaps throughout Wisconsin will ... digital inclusiveness as Milwaukee moves toward c... ,The City of Milwaukee , having finalized a cont... citywide wireless Internet network, will pursue f...ide, including the provision of low-cost or refurb...
...nd in city and state government is joining a new g...o attract federal grant money for start-up bioscie...Wisconsin lobbying firm Hamilton Consulting Group.... Sanders will focus on Hamilton,s new government ... in collaboration with the national economic devel...
...oping diagnostics to test for kidney disease is pr...ts to secure federal clearance for its first clini...a total of $3.2 million since its inception in 199... round for additional product research and develop...sed NEW Capital Fund , and also included Wisconsi...
Other Biology Technology:Locations must have connectivity to be viable 2Locations must have connectivity to be viable 3Locations must have connectivity to be viable 4Businesses could bridge digital divide in Milwaukee with used computers 2Businesses could bridge digital divide in Milwaukee with used computers 3Renovar captures $1.2M for product development 2
(Date:7/3/2008)...GE, Mass., July 3, 2008 -- Sirtris, a GlaxoSmithKl...small molecule drugs to treat diseases of aging su...h team that reported in today,s online edition of ...to the end-of-life with resveratrol showed an over...alth, a reduction in cataracts and cardiovascular ...
(Date:7/3/2008)...bservation satellites have provided vital informat...icularly long crisis response window following the...n 2 and 3 May 2008. , Immediately after the disa...tarian Affairs (OCHA) asked the International Char... ,the Charter, for support by providing immediate...
(Date:7/3/2008)... TexasA dynamic way to alter the shape and size of...t of proteins has been developed by biological che...ryan Kaehr at The University of Texas at Austin. ,...d three-dimensional microstructures, known as hydr...d the hydrogels by altering the chemistry of the e...
(Date:7/3/2008)... Moines, Iowa July 3, 2008 Endangered wild orang...harply in Sumatra and Borneo than previously estim...th by Great Ape Trust of Iowa scientist Dr. Serge ...Oryx The International Journal of Conservation . ...f orangutans, found only on the islands of Sumatra...
Breaking Biology News(10 mins):Long-term study of middle-aged mice shows 2Long-term study of middle-aged mice shows 3Extended cyclone relief efforts aided from space 2Extended cyclone relief efforts aided from space 3'Smart' materials get smarter with ability to better control shape and size 2'Smart' materials get smarter with ability to better control shape and size 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 4Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 5Scientists uncover the potential to control adult stem cells 2841 1Scientists uncover the potential to control adult stem cells 2841 2Consumerism Driving Healthcare Change 16463 1Consumerism Driving Healthcare Change 16463 2Loma Linda University Partners With Larta Institute for Technology Marketing Program 4519 1Loma Linda University Partners With Larta Institute for Technology Marketing Program 4519 2Postmenopausal Womens Sexual Dissatisfaction Not Linked to Heart Troubles 16462 1Postmenopausal Womens Sexual Dissatisfaction Not Linked to Heart Troubles 16462 2
...dresses western medicine & society,s embrace o...ns Medical Dean Edward Miller, and Georgetown Univ... With Western medicine,s increasing interest in me...g, the Mind & Life Institute, in partnership w...the Johns Hopkins University School of Medicine wi...
...ound in the Welsh national flower, which could off...eing supported for large scale manufacture by Card...(MEC). , Alzheimer,s disease is the most common fo... of dementia. Dementia affects one person in 20 ov...ge of 80. , Certain species of daffodil, which th...
... Florida researchers say they are a step closer to...ncers before symptoms become apparent. , The findi...tional Academy of Sciences, involve introducing mo...ures and observing whether they unleash a fluoresc..., The technique could enable doctors to search wit...
...t Stanford University have created a larger-than-n...ently as natural DNA. The findings, reported in th... National Academy of Sciences (PNAS), may reveal n...es that occur during DNA replication-arise. The di... professor of chemistry at Stanford and co-author ...
Other Biology News:Dalai Lama, top scientists to discuss science & clinical applications of meditation 2Dalai Lama, top scientists to discuss science & clinical applications of meditation 3Scientists closer to new cancer detection method 2Scientists closer to new cancer detection method 3DNA size a crucial factor in genetic mutations, study finds 2DNA size a crucial factor in genetic mutations, study finds 3